【摘要】MoS2 nanosheets and a doxorubicin (DOX)-containing poly(lactic-co-glycolic acid) (PLGA)/MoS2/DOX composite implant are successfully constructed based on the unique phase-changing behavior of PLGA/MoS2/DOX oleosol within tumors. The fast phase transformati